Register for our next Basics of Commercial Research Webinar (7th October 2025)
The trial seeks to evaluate the efficacy of an intervention tailored to support adult patients in cancer care awaiting psychological therapy. This intervention consists of a single remote session lasting 60-90 minutes within two weeks of referral to psychology service, followed by personalised automated smart messages designed to enhance motivation and behaviour change.
Patients in cancer care are at a heightened risk of experiencing mental health challenges, including an increased risk of suicide. However, these difficulties often go unnoticed, impacting both their quality of life and the effectiveness of cancer treatment. Currently, the wait time for psychological therapy ranges from four to ten weeks, during which symptoms may exacerbate. Moreover, engaging in therapy poses additional challenges, given patients' numerous commitments, necessitating an effective approach to maximise therapy benefits. Research suggests that a brief preparatory intervention can improve therapy outcomes, particularly when combined with technological support.
This proposed intervention, blending a single preparatory session with smart messaging, offers a cost-effective, easily implementable solution to enhance clinical outcomes and mental well-being among cancer patients. We aim to assess this intervention by comparing two groups of participants: One receiving the Therapy Preparation Intervention (TPI) alongside Treatment As Usual (TAU) and one receiving TAU alone. Participants consenting to take part in the study will be randomly allocated to one group and will be asked to complete five online questionnaires about their mental health and quality of life, each taking 20-30 minutes, over a 24-week period.
The hypotheses of the study are twofold:
Patients receiving both TPI and TAU will experience a greater reduction in depressive symptoms compared to those receiving TAU alone.
Patients receiving both TPI and TAU will exhibit lower dropout rates than those receiving TAU alone.
Identify participants who meet the study criteria (administering PHQ9)
Provide a brief introduction to the study
Obtain their consent to be contacted by the research team.
Refer patients with cancer who are currently experiencing depressive symptoms and are seeking access to psychological treatment to the trial researchers either through a telephone call or via NHS-to-NHS secure email address
Database Search
Screening Patient Lists for Eligibility
Mailout via SMS
Please note: The research team will then contact the participants to provide more detailed information and consent and recruit participants.
Aged 18 years or older
Able to engage with psychological therapy sessions conducted in English
Competent to give informed consent
Diagnosed with cancer and awaiting psychological therapy with EMCA CPH for symptoms of moderate-to-severe depression during the recruitment period of the study
A score of 10 or more on PHQ-9
Immediate risk to self or others
Currently receiving psychological therapy with another service.
Unable or unwilling to receive care remotely.
Opportunistic Approach: £102 fixed fee per practice undertaking the activity.
Consent to Contact: £4.33 per patient accepted onto the study.
For preparation and database search carried out: £26.50 fixed fee per practice undertaking the activity.
Screening eligibility check of patients: £62.00 fixed fee per practice undertaking the activity.